SCHRODER INVESTMENT MANAGEMENT GROUP - SORRENTO THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,736,000
-68.2%
373,382
-47.8%
0.00%
-75.0%
Q3 2021$5,454,000
-34.4%
714,821
-16.6%
0.01%
-20.0%
Q2 2021$8,308,000
+132.9%
857,297
+98.8%
0.01%
+100.0%
Q1 2021$3,567,000–431,238–0.01%–
 Download
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders